Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.64 |
| ▸ | CA1 | P00915 | 5/20 | 0.64 |
| ▸ | CA2 | P00918 | 5/20 | 0.64 |
| ▸ | CA6 | P23280 | 5/20 | 0.64 |
| ▸ | CA9 | Q16790 | 5/20 | 0.64 |
| ▸ | CA7 | P43166 | 4/20 | 0.64 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.64 |
| ▸ | CA4 | P22748 | 3/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | TTR | P02766 | 2/20 | 0.52 |
| ▸ | CA3 | P07451 | 3/20 | 0.50 |
| ▸ | CA5A | P35218 | 3/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL6507901 | 0.98 | CA12 (0.61) | CA12CA1CA2CA6CA9 | |
| SCHEMBL30436340 | 0.82 | CA12 (0.64) | CA12CA1CA2CA6CA9 | |
| SCHEMBL312791 | 0.82 | CA12 (0.64) | CA12CA1CA2CA6CA9 | |
| SCHEMBL29810232 | 0.81 | TTR (0.56) | CA12CA1CA2CA6CA9 | |
| SCHEMBL588825 | 0.81 | TTR (0.56) | CA12CA1CA2CA6CA9 | |
| SCHEMBL8252798 | 0.80 | LCK (0.53) | CA12CA1CA2CA9CA14 | |
| SCHEMBL10034774 | 0.80 | PKM (0.50) | CA2MAPTPOLBCA5AALDH1A1 | |
| SCHEMBL2771199 | 0.78 | CA12 (0.73) | CA12CA1CA2CA6CA9 | |
| Protocatechuic Acid SCHEMBL39435 | 0.78 | CA12 (1.00) | CA12CA1CA2CA6CA9 | |
| Protocatechuic Acid SCHEMBL30030432 | 0.78 | CA12 (1.00) | CA12CA1CA2CA6CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 319 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118252934-A | Application of HDC as stomach cancer cisplatin drug-resistant target | 浙江省肿瘤医院 | 2024-06-28 | — | — | CN | claimed |
| CN-114714724-B | Hot melt adhesive transfer film and preparation method thereof | 云阳金田塑业有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-114714724-A | Hot melt adhesive transfer film and preparation method thereof | 云阳金田塑业有限公司 | 2022-07-08 | — | — | CN | claimed |
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | LUMINIDE | 2005-04-14 | — | — | US | claimed |
| EP-4076460-B1 | 1,4-DIHYDRO-2H-SPIRO[ISOQUINOLINE-3,4'-PIPERIDINE DERIVATIVES AS PRMT5 INHIBITORS FOR THE TREATMENT OF CANCER | MERCK SHARP & DOHME LLC (US) | 2026-01-21 | — | — | EP | disclosed |
| US-12509460-B2 | Methods and compositions for modulating splicing | SKYHAWK THERAPEUTICS, INC. (US) | 2025-12-30 | — | — | US | disclosed |
| EP-4663626-A1 | IMINE COMPOUNDS AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | Bio Genuine (Shanghai) Biotech Co., Ltd (CN) | 2025-12-17 | — | — | EP | disclosed |
| EP-4653864-A1 | SEPARATION AGENT | Daicel Corporation (JP) | 2025-11-26 | — | — | EP | disclosed |
| US-12441730-B2 | PRMT5 inhibitors | MERCK SHARP & DOHME LLC (US) | 2025-10-14 | — | — | US | disclosed |
| US-20250282776-A1 | Bicyclic TLR7 Agonists and Uses Thereof | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-09-11 | — | — | US | disclosed |
| US-12403137-B2 | Compounds and methods of use | TANGO THERAPEUTICS, INC. (US) | 2025-09-02 | — | — | US | disclosed |
| CN-119948034-A | Novel peptide-based nitrile compound and application thereof | 上海壹迪生物技术有限公司 | 2025-05-06 | — | — | CN | disclosed |
| US-4886869-A | OPTIONALLY SUBSTITUTED WITH-3-HYDROXY BENZOIC ACID; RIGIDITY, IMPACT STRENGTH AND ELONGATION | BAYER AKTIENGESELLSCHAFT (DE) | 1989-12-12 | — | — | US | disclosed |
| WO-1989009833-A1 | LUMINIDE AND MACROLUMINIDE CLASS OF PHARMACEUTICALS | MILLS RANDELL L (US) | 1989-10-19 | — | — | WO | disclosed |
| EP-0044205-B1 | POLYESTER OF 6-HYDROXY-2-NAPHTHOIC ACID AND METAHYDROXY BENZOIC ACID CAPABLE OF READILY UNDERGOING MELT PROCESSING | CELANESE CORPORATION (US) | 1985-04-10 | — | — | EP | disclosed |
| EP-0006125-B1 | PHOTOPOLYMERISABLE MIXTURE AND LIGHT-SENSITIVE COATING MATERIAL | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-05-11 | — | — | EP | disclosed |
| US-4337190-A | Polyester of 6-hydroxy-2-naphthoic acid and meta-hydroxy benzoic acid capable of readily undergoing melt processing | CELANESE CORPORATION (US) | 1982-06-29 | — | — | US | disclosed |
| EP-0044205-A1 | Polyester of 6-hydroxy-2-naphthoic acid and metahydroxy benzoic acid capable of readily undergoing melt processing | CELANESE CORPORATION (US) | 1982-01-20 | — | — | EP | disclosed |
| US-4245030-A | Photopolymerizable mixture containing improved plasticizer | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-01-13 | — | — | US | disclosed |
| EP-0006125-A1 | Photopolymerisable mixture and light-sensitive coating material | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-01-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | APEH, PAH, ALAD | CA12 1448/4885CA1 2423/4885CA2 3018/4885 |
| US-20250282776-A1 | Bicyclic TLR7 Agonists and Uses Thereof | TLR7, TLR9, TLR1 | CA12 3176/4885CA1 4343/4885CA2 4074/4885 |
| US-12509460-B2 | Methods and compositions for modulating splicing | SF3B1, RTCB, RBM17 | CA12 4814/4885CA1 4526/4885CA2 4755/4885 |
| US-12403137-B2 | Compounds and methods of use | XDH, LPXN, F12 | CA12 1141/4885CA1 1360/4885CA2 1078/4885 |
| US-12441730-B2 | PRMT5 inhibitors | PRMT5, PRMT1, PRMT3 | CA12 4534/4885CA1 3927/4885CA2 3181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.